| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82531 |
Azido-PEG5-CH2CO2-PFP,CAS号:2144777-92-2 |
185 |
h |
2024-12-24 |
| 82532 |
Boc-NHCH2CH2-PEG1-azide,CAS号:176220-30-7 |
135 |
h |
2024-12-24 |
| 82533 |
Boc-NH-PEG5-CH2COOH,叔丁氧羰基氨基-五聚乙二醇-乙酸 |
171 |
wyh |
2024-12-24 |
| 82534 |
Folate-Doxorubicin Liposome (PEGylated),叶酸-阿霉素脂质体(聚乙二醇化) |
187 |
axc |
2024-12-24 |
| 82535 |
Azido-PEG10-CH2CO2-NHS |
243 |
h |
2024-12-24 |
| 82536 |
Azide-Doxorubicin Liposome (PEGylated),叠氮阿霉素脂质体(聚乙二醇化) |
240 |
axc |
2024-12-24 |
| 82537 |
Azido-PEG3-CH2CO2Me,CAS号:1253389-31-9 |
269 |
h |
2024-12-24 |
| 82538 |
DBCO-Doxorubicin Liposome (PEGylated),DBCO-阿霉素脂质体(聚乙二醇化) |
190 |
axc |
2024-12-24 |
| 82539 |
Azido-PEG5-CH2CO2-NHS,CAS号:2144777-77-3 |
189 |
h |
2024-12-24 |
| 82540 |
DIBAC-GGFG-NH2CH2-Dxd,CAS号:2758875-01-1 |
168 |
h |
2024-12-24 |
| 82541 |
Amine-Doxorubicin Liposome (PEGylated),胺-阿霉素脂质体(聚乙二醇化) |
165 |
axc |
2024-12-24 |
| 82542 |
HO-PEG-CH2COOH (MW 35000) |
153 |
h |
2024-12-24 |
| 82543 |
Azido-PEG5-CH2CO2H,CAS号:217180-81-9 |
160 |
h |
2024-12-24 |
| 82544 |
Biotin-Doxorubicin Liposome (PEGylated),生物素-阿霉素脂质体(聚乙二醇化) |
170 |
axc |
2024-12-24 |
| 82545 |
H2N-PEG2-CH2COOtBu,CAS号:1122484-77-8 |
152 |
h |
2024-12-24 |
| 82546 |
H2N-PEG2-CH2COOH |
158 |
h |
2024-12-24 |
| 82547 |
Cyanur-Doxorubicin Liposome (PEGylated),氰尿多柔比星脂质体(聚乙二醇化) |
319 |
axc |
2024-12-24 |
| 82548 |
N3-PEG8-CH2COOH,CAS号:1343472-07-0 |
172 |
h |
2024-12-24 |
| 82549 |
PEG5-(CH2CO2t-Butyl)2的物理化学性质,211746-78-0 |
161 |
wyh |
2024-12-24 |
| 82550 |
Succinyl-Doxorubicin Liposome (PEGylated),琥珀酰阿霉素脂质体(聚乙二醇化) |
156 |
axc |
2024-12-24 |
| 82551 |
4-Ketobenztriazine-CH2COOH |
193 |
h |
2024-12-24 |
| 82552 |
MC-Val-Cit-PAB-PNP,159857-81-5 ,抗体- 药物偶联物 |
245 |
hyy |
2024-12-24 |
| 82553 |
Fmoc-Asp(OtBu)-CH2COOH,CAS号:1803002-89-2 |
198 |
h |
2024-12-24 |
| 82554 |
Fmoc-G-amino-CH2O acetyl-Exetecan的化学结构,1599440-09-1 |
220 |
wyh |
2024-12-24 |
| 82555 |
Carboxylic Acid-Doxorubicin Liposome (PEGylated),羧酸-阿霉素脂质体(聚乙二醇化) |
217 |
axc |
2024-12-24 |
| 82556 |
t-Butyl acetate-PEG2-CH2COOH,CAS号:883564-93-0 |
163 |
h |
2024-12-24 |
| 82557 |
Azido-PEG8-CH2COO-PFP,CAS号:2182601-80-3 |
122 |
h |
2024-12-24 |
| 82558 |
Control Doxorubicin Liposome (PEGylated),对照阿霉素脂质体(聚乙二醇化) |
167 |
axc |
2024-12-24 |
| 82559 |
Azido-PEG1-CH2CO2H,CAS号:79598-48-4 |
172 |
h |
2024-12-24 |
| 82560 |
Propargyl-PEG4-CH2CO2-NHS,CAS号:2144777-76-2 |
145 |
h |
2024-12-24 |
| 82561 |
Doxorubicin Liposome (PEGylated),阿霉素脂质体(聚乙二醇化) |
2024 |
axc |
2024-12-24 |
| 82562 |
Cbz-NH-PEG3-CH2COOH,CAS号:462100-05-6 |
169 |
h |
2024-12-24 |
| 82563 |
Control High Potency Clodronate Liposome (Anionic),对照高效氯膦酸盐脂质体(阴离子) |
157 |
axc |
2024-12-24 |
| 82564 |
Cbz-NH-PEG2-CH2COOH,CAS号:165454-06-8,8-苄氧羰基氨基-3,6-二氧杂辛酸 |
158 |
h |
2024-12-24 |
| 82565 |
Cbz-NH-PEG5-CH2COOH,CAS号:1449390-66-2 |
146 |
h |
2024-12-24 |
| 82566 |
Cbz-NH-PEG1-CH2COOH,CAS号:1260092-43-0 |
242 |
h |
2024-12-24 |
| 82567 |
Fmoc-NH-PEG12-CH2COOH,CAS号:2291257-76-4 |
152 |
h |
2024-12-24 |
| 82568 |
Boc-NH-PEG1-CH2COOH |
157 |
h |
2024-12-24 |
| 82569 |
Fmoc-NH-PEG11-CH2COOH,CAS号:2629308-66-1 |
112 |
h |
2024-12-24 |
| 82570 |
Boc-Aminooxy-PEG2-CH2COOH,CAS号:2098983-14-1 |
184 |
h |
2024-12-24 |
| 82571 |
11-马来酰胺基十一烷酸,11-Maleimidoundecanoic acid |
157 |
wyh |
2024-12-24 |
| 82572 |
Mc-Val-Cit-PABC-PNP,159857-81-5 ,抗体- 药物偶联物 |
129 |
hyy |
2024-12-24 |
| 82573 |
m-PEG7-(CH2)3-alcohol ,甲氧基-七聚乙二醇-三个亚甲基-乙醇 |
184 |
wyh |
2024-12-24 |
| 82574 |
m-PEG6-(CH2)8-phosphonic acid的化学性质,2028284-71-9 |
121 |
wyh |
2024-12-24 |
| 82575 |
Fmoc-amino-PEG3-CH2COOH,Fmoc-11-氨基-3,6,9-三氧杂十一酸,CAS号:139338-72-0 |
238 |
h |
2024-12-24 |